Featured Videos View All »
Video
The COPD Blues: A Guide to Optimizing Outpatient Management
For the 30 million adults in the U.S. with COPD, effective care requires providers to have an up-to-date understanding of treatment options as well as the ability to respond to changes in a patient’s status.
Video
Breathing Easier: An Update on Diagnosis and Management of Asthma
Allergist and immunologist Monica Tang, MD, discusses keys to distinguishing asthma from other disorders.
Video
Long COVID: A New Way to Look at a Growing Problem
Synthesizing multiple studies, pulmonologist Brian Block, MD, reveals which patients are at risk for lasting symptoms from infection with the coronavirus (it’s not who you might think).
Video
COVID Care and Control: How to Use What We’ve Learned So Far
Pulmonologist Brian Block, MD, submits an enlightening analysis of U.S. COVID data, including his own work examining mortality in overburdened hospitals.
Articles & Documents View All »
News
New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis
In a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.
News
UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life
Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years Later
News
In a collaborative study between UCSF researchers appearing December 30 in Nature Cell Biology, UCSF researchers Jaymin Kathiriya, PhD, and Chaoqun Wang, PhD, discovered that severe lung injuries can trigger lung stem cells to undergo ...
News
Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control ...
The Mission of the Pulmonary, Critical Care, Allergy and Sleep Medicine Program is to be a leader in the provision of comprehensive medical care to patients with pulmonary disease, critical illness, allergic diseases and sleep disorders, to be an engine for innovative research aimed at elucidating basic mechanisms of disease, to translate our research activities into new clinical initiatives, and to provide a rich training environment for the next generation of international leaders in basic, translational and clinical research.
